Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Parametric identification and public health measures influence on the COVID-19 epidemic evolution in Brazil

View ORCID ProfileR.M. Cotta, View ORCID ProfileC.P. Naveira-Cotta, View ORCID ProfileP. Magal
doi: https://doi.org/10.1101/2020.03.31.20049130
R.M. Cotta
1General Directorate of Nuclear and Technological Development, DGDNTM, Brazilian Navy, Rio de Janeiro, RJ, Brazil
2Laboratory of Nano & Microfluidics and Microsystems, LabMEMS, Mechanical Engineering Dept., POLI & COPPE, UFRJ, Federal University of Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R.M. Cotta
  • For correspondence: cotta@mecanica.coppe.ufrj.br
C.P. Naveira-Cotta
2Laboratory of Nano & Microfluidics and Microsystems, LabMEMS, Mechanical Engineering Dept., POLI & COPPE, UFRJ, Federal University of Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C.P. Naveira-Cotta
P. Magal
3Institut de Mathématiques de, Université de Bordeaux, 351 cours de la libération 33400 Talence, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Magal
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

A SIRU-type epidemic model is employed for the prediction of the COVID-19 epidemy evolution in Brazil, and analyse the influence of public health measures on simulating the control of this infectious disease. Since the reported cases are typically only a fraction of the total number of the symptomatic infectious individuals, the model accounts for both reported and unreported cases. Also, the model allows for a time variable functional form of both the transmission rate and the fraction of asymptomatic infectious that become reported symptomatic individuals, so as to reflect public health interventions, towards its control, along the course of the epidemic evolution. An analytical exponential behaviour for the accumulated reported cases evolution is assumed at the onset of the epidemy, for explicitly estimating initial conditions, while a Bayesian inference approach is adopted for parametric estimations employing the present direct problem model with the data from the known portion of the epidemics evolution, represented by the time series for the reported cases of infected individuals. The direct-inverse problem analysis is then employed with the actual data from China, with the initial phase of the data been employed for the parametric estimation and the remaining data being used for validation of the predictive capability of the proposed approach. The full dataset for China is then employed in another parameter identification, aimed at refining the values for the average times that asymptomatic infectious individuals and that symptomatic individuals remain infectious. Following this validation, the available data on reported cases in Brazil from February 15th till March 29th, 2020, is used for estimating parameters and then predict the epidemy evolution from these initial conditions. As for the China analysis, the data for the reported cases in Brazil from March 30th till April 23rd are reserved for validation of the model. Finally, public health interventions are simulated, aimed at evaluating the effects on the disease spreading, by acting on both the transmission rate and the fraction of the total number of the symptomatic infectious individuals, considering time variable exponential behaviours for these two parameters, usually assumed constant in epidemic evolutions without intervention. It is demonstrated that a combination of actions to affect both parameters can have a more effective result in the control of the epidemy dynamics.

NOMENCLATURE

View this table:
  • View inline
  • View popup
  • Download powerpoint
View this table:
  • View inline
  • View popup
  • Download powerpoint

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is partially funded by CNPq and FAPERJ, both governmental sponsoring agencies in Brasil.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available upon request from the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 12, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Parametric identification and public health measures influence on the COVID-19 epidemic evolution in Brazil
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Parametric identification and public health measures influence on the COVID-19 epidemic evolution in Brazil
R.M. Cotta, C.P. Naveira-Cotta, P. Magal
medRxiv 2020.03.31.20049130; doi: https://doi.org/10.1101/2020.03.31.20049130
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Parametric identification and public health measures influence on the COVID-19 epidemic evolution in Brazil
R.M. Cotta, C.P. Naveira-Cotta, P. Magal
medRxiv 2020.03.31.20049130; doi: https://doi.org/10.1101/2020.03.31.20049130

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5219)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5823)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (94)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1995)
  • Radiology and Imaging (345)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)